HEADER IMMUNE SYSTEM 23-DEC-20 7L6M TITLE CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER FROM LOCAL REFINEMENT OF THE TITLE 2 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TITLE 3 TRIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: DH898.1 FAB LIGHT CHAIN; COMPND 3 CHAIN: g, j; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DH898.1 FAB HEAVY CHAIN; COMPND 7 CHAIN: h, i; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MACACA MULATTA; SOURCE 3 ORGANISM_TAXID: 9544; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MACACA MULATTA; SOURCE 8 ORGANISM_TAXID: 9544; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS FAB-DIMERIZED, GLYCAN-REACTIVE, ANTIBODIES, HIV-1, DH898.1, FAB- KEYWDS 2 DIMER, GLYCAN-REACTIVE NEUTRALIZING ANTIBODY, MACAQUE HIV-1 VACCINE- KEYWDS 3 INDUCED, B CELL LINEAGE, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR K.MANNE,R.J.EDWARDS,P.ACHARYA REVDAT 4 09-JUN-21 7L6M 1 JRNL REVDAT 3 02-JUN-21 7L6M 1 JRNL REVDAT 2 24-MAR-21 7L6M 1 REMARK DBREF HELIX SHEET REVDAT 2 2 1 SSBOND ATOM REVDAT 1 10-FEB-21 7L6M 0 JRNL AUTH W.B.WILLIAMS,R.R.MEYERHOFF,R.J.EDWARDS,H.LI,K.MANNE, JRNL AUTH 2 N.I.NICELY,R.HENDERSON,Y.ZHOU,K.JANOWSKA,K.MANSOURI, JRNL AUTH 3 S.GOBEIL,T.EVANGELOUS,B.HORA,M.BERRY,A.Y.ABUAHMAD,J.SPRENZ, JRNL AUTH 4 M.DEYTON,V.STALLS,M.KOPP,A.L.HSU,M.J.BORGNIA, JRNL AUTH 5 G.B.E.STEWART-JONES,M.S.LEE,N.BRONKEMA,M.A.MOODY,K.WIEHE, JRNL AUTH 6 T.BRADLEY,S.M.ALAM,R.J.PARKS,A.FOULGER,T.OGUIN, JRNL AUTH 7 G.D.SEMPOWSKI,M.BONSIGNORI,C.C.LABRANCHE,D.C.MONTEFIORI, JRNL AUTH 8 M.SEAMAN,S.SANTRA,J.PERFECT,J.R.FRANCICA,G.M.LYNN, JRNL AUTH 9 B.AUSSEDAT,W.E.WALKOWICZ,R.LAGA,G.KELSOE,K.O.SAUNDERS, JRNL AUTH10 D.FERA,P.D.KWONG,R.A.SEDER,A.BARTESAGHI,G.M.SHAW,P.ACHARYA, JRNL AUTH11 B.F.HAYNES JRNL TITL FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES ARE A STRUCTURAL JRNL TITL 2 CATEGORY OF NATURAL ANTIBODIES. JRNL REF CELL V. 184 2955 2021 JRNL REFN ISSN 1097-4172 JRNL PMID 34019795 JRNL DOI 10.1016/J.CELL.2021.04.042 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.ACHARYA,W.WILLIAMS,R.HENDERSON,K.JANOWSKA,K.MANNE,R.PARKS, REMARK 1 AUTH 2 M.DEYTON,J.SPRENZ,V.STALLS,M.KOPP,K.MANSOURI,R.J.EDWARDS, REMARK 1 AUTH 3 R.R.MEYERHOFF,T.OGUIN,G.SEMPOWSKI,K.SAUNDERS,B.F.HAYNES REMARK 1 TITL FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES NEUTRALIZE HIV AND REMARK 1 TITL 2 ARE PREVALENT IN HUMANS AND RHESUS MACAQUES REMARK 1 REF BIORXIV 2020 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2020.06.30.178921 REMARK 2 REMARK 2 RESOLUTION. 4.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : LATITUDE, CRYOSPARC, UCSF CHIMERA, REMARK 3 COOT, CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, COOT, PHENIX, ISOLDE REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.700 REMARK 3 NUMBER OF PARTICLES : 59012 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7L6M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253788. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : LOCAL REFINEMENT OF DH898.1 FAB REMARK 245 -DIMER BOUND NEAR CD4BS OF REMARK 245 CH848 TRIMER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOT FOR 2.5 SECONDS BEFORE REMARK 245 PLUNGING REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 3230 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6200.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: g, h, i, j REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HG SER g 77 OE1 GLU g 79 1.56 REMARK 500 HG1 THR j 14 OE2 GLU j 17 1.58 REMARK 500 OD1 ASP i 72 HG SER i 74 1.59 REMARK 500 HG SER j 77 OE2 GLU j 79 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG g 61 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG h 12 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG h 38 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG h 66 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG h 210 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG h 210 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ARG i 12 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 TYR i 27 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES REMARK 500 ARG i 94 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG i 129 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU g 27B 48.42 -104.55 REMARK 500 ASN g 28 40.14 -71.50 REMARK 500 LEU g 47 -68.46 -128.33 REMARK 500 ASP g 60 8.92 -69.46 REMARK 500 VAL g 92 -45.66 -162.06 REMARK 500 ALA g 93 -1.83 -143.47 REMARK 500 TRP g 96 85.79 -65.17 REMARK 500 ASN g 138 60.95 70.67 REMARK 500 PRO g 141 -176.36 -65.30 REMARK 500 GLU g 165 53.25 -68.81 REMARK 500 GLN g 166 -126.53 60.02 REMARK 500 LYS g 169 -88.74 -92.27 REMARK 500 THR g 172 -158.22 -76.43 REMARK 500 ASN g 190 -40.33 -146.88 REMARK 500 ASP h 2 81.18 -66.35 REMARK 500 SER h 7 -156.62 -131.11 REMARK 500 ALA h 16 -146.55 -86.98 REMARK 500 ASN h 26 96.58 -63.96 REMARK 500 THR h 28 64.06 -69.02 REMARK 500 THR h 57 -50.99 -128.65 REMARK 500 GLU h 96 -39.54 -158.83 REMARK 500 PRO h 97 -117.68 -85.51 REMARK 500 ASP h 98 34.98 -73.95 REMARK 500 SER h 128 18.31 58.76 REMARK 500 THR h 131 -8.76 -154.45 REMARK 500 SER h 134 -14.06 -177.25 REMARK 500 ASP h 144 23.31 46.96 REMARK 500 SER h 188 91.51 -65.30 REMARK 500 SER i 25 -158.45 -80.58 REMARK 500 ASN i 26 69.94 -68.45 REMARK 500 ILE i 63 -94.76 -119.83 REMARK 500 ARG i 64 2.68 51.29 REMARK 500 ASP i 65 -57.08 -124.16 REMARK 500 THR i 70 -168.48 -166.45 REMARK 500 THR i 75 -4.39 -145.45 REMARK 500 PRO i 97 -18.80 -47.97 REMARK 500 TRP i 100C -159.32 -156.89 REMARK 500 PRO i 113 0.34 -67.00 REMARK 500 ALA i 114 170.66 -57.88 REMARK 500 LEU i 124 -65.37 -133.37 REMARK 500 SER i 132 71.17 -66.38 REMARK 500 SER i 134 -73.85 -166.02 REMARK 500 ALA i 136 -152.87 -133.97 REMARK 500 THR i 160 -41.40 -141.55 REMARK 500 THR i 191 -66.95 -145.09 REMARK 500 ASN j 28 -8.70 65.62 REMARK 500 ASN j 30 73.95 -150.26 REMARK 500 LYS j 39 -131.57 -134.18 REMARK 500 ALA j 40 61.23 -69.06 REMARK 500 LEU j 47 -53.32 -123.31 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR h 90 0.07 SIDE CHAIN REMARK 500 TYR h 91 0.07 SIDE CHAIN REMARK 500 ARG h 94 0.09 SIDE CHAIN REMARK 500 TYR h 145 0.09 SIDE CHAIN REMARK 500 TYR i 32 0.09 SIDE CHAIN REMARK 500 TYR i 33 0.08 SIDE CHAIN REMARK 500 TYR j 36 0.07 SIDE CHAIN REMARK 500 TYR j 140 0.07 SIDE CHAIN REMARK 500 TYR j 192 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6XRJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE DISULFIDE LINKED DH717.1 FAB DIMER, REMARK 900 DERIVED FROM A MACAQUE HIV-1 VACCINE-INDUCED ENV GLYCAN-REACTIVE REMARK 900 NEUTRALIZING ANTIBODY B CELL LINEAGE REMARK 900 RELATED ID: EMD-23145 RELATED DB: EMDB DBREF 7L6M g 1 213 PDB 7L6M 7L6M 1 213 DBREF 7L6M h 1 212 PDB 7L6M 7L6M 1 212 DBREF 7L6M i 1 212 PDB 7L6M 7L6M 1 212 DBREF 7L6M j 1 213 PDB 7L6M 7L6M 1 213 SEQRES 1 g 218 GLU ILE VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 g 218 THR PRO GLY GLU PRO ALA SER LEU SER CYS ARG SER SER SEQRES 3 g 218 ALA SER LEU LEU HIS GLY ASN GLY ASN THR TYR LEU HIS SEQRES 4 g 218 TRP TYR LEU ARG LYS ALA GLY GLN SER PRO GLN LEU LEU SEQRES 5 g 218 ILE PHE GLY GLY SER LYS ARG VAL PRO GLY ILE SER ASP SEQRES 6 g 218 ARG PHE ILE GLY SER GLY ALA GLY THR ASN PHE THR LEU SEQRES 7 g 218 LYS ILE SER SER VAL GLU ALA ASP ASP VAL GLY PHE TYR SEQRES 8 g 218 TYR CYS ALA GLN GLY VAL ALA PHE PRO TRP THR PHE GLY SEQRES 9 g 218 GLN GLY THR LYS VAL GLU ILE LYS ARG ALA VAL ALA ALA SEQRES 10 g 218 PRO SER VAL PHE ILE PHE PRO PRO SER GLU ASP GLN VAL SEQRES 11 g 218 LYS SER GLY THR VAL SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 g 218 PHE TYR PRO ARG GLU ALA SER VAL LYS TRP LYS VAL ASP SEQRES 13 g 218 GLY VAL LEU LYS THR GLY ASN SER GLN GLU SER VAL THR SEQRES 14 g 218 GLU GLN ASP SER LYS ASP ASN THR TYR SER LEU SER SER SEQRES 15 g 218 THR LEU THR LEU SER ASN THR ASP TYR GLN SER HIS ASN SEQRES 16 g 218 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 g 218 PRO VAL THR LYS SER PHE ASN ARG GLY GLU SEQRES 1 h 219 GLN ASP LEU LEU LEU GLN SER GLY ALA GLU VAL ARG GLU SEQRES 2 h 219 PRO GLY ALA SER VAL THR VAL SER CYS GLN ALA SER ASN SEQRES 3 h 219 TYR THR PHE PRO ASP TYR TYR ILE HIS TRP VAL ARG LEU SEQRES 4 h 219 VAL PRO GLY GLN GLY LEU GLU TRP LEU GLY GLU MET LYS SEQRES 5 h 219 PRO LYS VAL GLY VAL THR ASN VAL SER LYS LYS ILE ARG SEQRES 6 h 219 ASP ARG LEU PHE MET THR ALA ASP THR SER THR ASP THR SEQRES 7 h 219 ALA TYR MET VAL LEU SER ALA LEU THR PRO GLY ASP THR SEQRES 8 h 219 ALA ILE TYR TYR CYS THR ARG LEU GLU PRO ASP PHE LEU SEQRES 9 h 219 SER GLY TRP ALA HIS TRP GLY LYS GLY VAL LEU VAL THR SEQRES 10 h 219 VAL SER PRO ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 h 219 LEU ALA PRO SER SER ARG SER THR SER GLU SER THR ALA SEQRES 12 h 219 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 h 219 VAL THR VAL SER TRP ASN SER GLY SER LEU THR SER GLY SEQRES 14 h 219 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 h 219 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 h 219 LEU GLY THR GLN THR TYR VAL CYS ASN VAL ASN HIS LYS SEQRES 17 h 219 PRO SER ASN THR LYS VAL ASP LYS ARG VAL GLU SEQRES 1 i 219 GLN ASP LEU LEU LEU GLN SER GLY ALA GLU VAL ARG GLU SEQRES 2 i 219 PRO GLY ALA SER VAL THR VAL SER CYS GLN ALA SER ASN SEQRES 3 i 219 TYR THR PHE PRO ASP TYR TYR ILE HIS TRP VAL ARG LEU SEQRES 4 i 219 VAL PRO GLY GLN GLY LEU GLU TRP LEU GLY GLU MET LYS SEQRES 5 i 219 PRO LYS VAL GLY VAL THR ASN VAL SER LYS LYS ILE ARG SEQRES 6 i 219 ASP ARG LEU PHE MET THR ALA ASP THR SER THR ASP THR SEQRES 7 i 219 ALA TYR MET VAL LEU SER ALA LEU THR PRO GLY ASP THR SEQRES 8 i 219 ALA ILE TYR TYR CYS THR ARG LEU GLU PRO ASP PHE LEU SEQRES 9 i 219 SER GLY TRP ALA HIS TRP GLY LYS GLY VAL LEU VAL THR SEQRES 10 i 219 VAL SER PRO ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 i 219 LEU ALA PRO SER SER ARG SER THR SER GLU SER THR ALA SEQRES 12 i 219 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 i 219 VAL THR VAL SER TRP ASN SER GLY SER LEU THR SER GLY SEQRES 14 i 219 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 i 219 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 i 219 LEU GLY THR GLN THR TYR VAL CYS ASN VAL ASN HIS LYS SEQRES 17 i 219 PRO SER ASN THR LYS VAL ASP LYS ARG VAL GLU SEQRES 1 j 218 GLU ILE VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 j 218 THR PRO GLY GLU PRO ALA SER LEU SER CYS ARG SER SER SEQRES 3 j 218 ALA SER LEU LEU HIS GLY ASN GLY ASN THR TYR LEU HIS SEQRES 4 j 218 TRP TYR LEU ARG LYS ALA GLY GLN SER PRO GLN LEU LEU SEQRES 5 j 218 ILE PHE GLY GLY SER LYS ARG VAL PRO GLY ILE SER ASP SEQRES 6 j 218 ARG PHE ILE GLY SER GLY ALA GLY THR ASN PHE THR LEU SEQRES 7 j 218 LYS ILE SER SER VAL GLU ALA ASP ASP VAL GLY PHE TYR SEQRES 8 j 218 TYR CYS ALA GLN GLY VAL ALA PHE PRO TRP THR PHE GLY SEQRES 9 j 218 GLN GLY THR LYS VAL GLU ILE LYS ARG ALA VAL ALA ALA SEQRES 10 j 218 PRO SER VAL PHE ILE PHE PRO PRO SER GLU ASP GLN VAL SEQRES 11 j 218 LYS SER GLY THR VAL SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 j 218 PHE TYR PRO ARG GLU ALA SER VAL LYS TRP LYS VAL ASP SEQRES 13 j 218 GLY VAL LEU LYS THR GLY ASN SER GLN GLU SER VAL THR SEQRES 14 j 218 GLU GLN ASP SER LYS ASP ASN THR TYR SER LEU SER SER SEQRES 15 j 218 THR LEU THR LEU SER ASN THR ASP TYR GLN SER HIS ASN SEQRES 16 j 218 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 j 218 PRO VAL THR LYS SER PHE ASN ARG GLY GLU HELIX 1 AA1 GLU g 79 VAL g 83 5 5 HELIX 2 AA2 SER g 121 LYS g 126 1 6 HELIX 3 AA3 ASN g 183 HIS g 189 1 7 HELIX 4 AA4 THR h 28 TYR h 32 5 5 HELIX 5 AA5 ASP h 98 GLY h 100B 5 5 HELIX 6 AA6 TRP h 154 SER h 158 5 5 HELIX 7 AA7 SER h 188 TYR h 194 5 7 HELIX 8 AA8 LYS h 201 ASN h 204 5 4 HELIX 9 AA9 THR i 83 THR i 87 5 5 HELIX 10 AB1 ASP i 98 GLY i 100B 5 5 HELIX 11 AB2 SER i 186 GLY i 190 1 5 HELIX 12 AB3 GLU j 79 VAL j 83 5 5 HELIX 13 AB4 SER j 121 SER j 127 1 7 HELIX 14 AB5 ASN j 183 SER j 188 1 6 SHEET 1 AA1 4 MET g 4 THR g 7 0 SHEET 2 AA1 4 ALA g 19 SER g 25 -1 O ARG g 24 N THR g 5 SHEET 3 AA1 4 ASN g 70 ILE g 75 -1 O ILE g 75 N ALA g 19 SHEET 4 AA1 4 PHE g 62 ALA g 67 -1 N ILE g 63 O LYS g 74 SHEET 1 AA2 6 SER g 10 VAL g 13 0 SHEET 2 AA2 6 THR g 102 ILE g 106 1 O GLU g 105 N LEU g 11 SHEET 3 AA2 6 GLY g 84 GLN g 90 -1 N TYR g 86 O THR g 102 SHEET 4 AA2 6 LEU g 33 ARG g 38 -1 N TYR g 36 O TYR g 87 SHEET 5 AA2 6 GLN g 45 PHE g 49 -1 O GLN g 45 N LEU g 37 SHEET 6 AA2 6 LYS g 53 ARG g 54 -1 O LYS g 53 N PHE g 49 SHEET 1 AA3 4 SER g 114 PHE g 118 0 SHEET 2 AA3 4 THR g 129 PHE g 139 -1 O LEU g 135 N PHE g 116 SHEET 3 AA3 4 TYR g 173 SER g 182 -1 O LEU g 175 N LEU g 136 SHEET 4 AA3 4 GLN g 160 VAL g 163 -1 N SER g 162 O SER g 176 SHEET 1 AA4 4 VAL g 153 LEU g 154 0 SHEET 2 AA4 4 ALA g 144 VAL g 150 -1 N VAL g 150 O VAL g 153 SHEET 3 AA4 4 VAL g 191 HIS g 198 -1 O THR g 197 N SER g 145 SHEET 4 AA4 4 VAL g 205 ASN g 210 -1 O PHE g 209 N TYR g 192 SHEET 1 AA5 4 LEU h 4 LEU h 5 0 SHEET 2 AA5 4 ALA h 16 ALA h 24 -1 O GLN h 23 N LEU h 5 SHEET 3 AA5 4 THR h 77 LEU h 82C-1 O MET h 80 N VAL h 20 SHEET 4 AA5 4 LEU h 67 ASP h 72 -1 N PHE h 68 O VAL h 81 SHEET 1 AA6 6 GLU h 10 ARG h 12 0 SHEET 2 AA6 6 VAL h 107 VAL h 111 1 O LEU h 108 N GLU h 10 SHEET 3 AA6 6 ALA h 88 CYS h 92 -1 N ALA h 88 O VAL h 109 SHEET 4 AA6 6 ILE h 34 LEU h 39 -1 N LEU h 39 O ILE h 89 SHEET 5 AA6 6 LEU h 45 LYS h 52 -1 O GLU h 46 N ARG h 38 SHEET 6 AA6 6 GLY h 55 VAL h 59 -1 O ASN h 58 N GLU h 50 SHEET 1 AA7 4 SER h 120 LEU h 124 0 SHEET 2 AA7 4 THR h 135 TYR h 145 -1 O LYS h 143 N SER h 120 SHEET 3 AA7 4 TYR h 176 PRO h 185 -1 O TYR h 176 N TYR h 145 SHEET 4 AA7 4 VAL h 163 LEU h 170 -1 N HIS h 164 O VAL h 181 SHEET 1 AA8 3 THR h 151 SER h 153 0 SHEET 2 AA8 3 CYS h 196 HIS h 200 -1 O ASN h 199 N THR h 151 SHEET 3 AA8 3 THR h 205 LYS h 209 -1 O THR h 205 N HIS h 200 SHEET 1 AA9 4 LEU i 5 GLN i 6 0 SHEET 2 AA9 4 VAL i 18 GLN i 23 -1 O GLN i 23 N LEU i 5 SHEET 3 AA9 4 ALA i 78 LEU i 82 -1 O LEU i 82 N VAL i 18 SHEET 4 AA9 4 PHE i 68 ALA i 71 -1 N PHE i 68 O VAL i 81 SHEET 1 AB1 6 GLU i 10 ARG i 12 0 SHEET 2 AB1 6 VAL i 107 VAL i 111 1 O THR i 110 N ARG i 12 SHEET 3 AB1 6 ALA i 88 ARG i 94 -1 N TYR i 90 O VAL i 107 SHEET 4 AB1 6 ILE i 34 LEU i 39 -1 N LEU i 39 O ILE i 89 SHEET 5 AB1 6 GLU i 46 LYS i 52 -1 O MET i 51 N ILE i 34 SHEET 6 AB1 6 VAL i 56 VAL i 59 -1 O ASN i 58 N GLU i 50 SHEET 1 AB2 4 SER i 120 PRO i 123 0 SHEET 2 AB2 4 THR i 135 TYR i 145 -1 O LYS i 143 N SER i 120 SHEET 3 AB2 4 TYR i 176 PRO i 185 -1 O LEU i 178 N VAL i 142 SHEET 4 AB2 4 VAL i 163 LEU i 170 -1 N HIS i 164 O VAL i 181 SHEET 1 AB3 3 THR i 151 TRP i 154 0 SHEET 2 AB3 3 TYR i 194 HIS i 200 -1 O ASN i 197 N SER i 153 SHEET 3 AB3 3 THR i 205 VAL i 211 -1 O VAL i 207 N VAL i 198 SHEET 1 AB4 4 THR j 5 THR j 7 0 SHEET 2 AB4 4 ALA j 19 ARG j 24 -1 O SER j 22 N THR j 7 SHEET 3 AB4 4 ASN j 70 ILE j 75 -1 O PHE j 71 N CYS j 23 SHEET 4 AB4 4 GLY j 64 SER j 65 -1 N SER j 65 O THR j 72 SHEET 1 AB5 6 SER j 10 VAL j 13 0 SHEET 2 AB5 6 THR j 102 ILE j 106 1 O GLU j 105 N VAL j 13 SHEET 3 AB5 6 GLY j 84 ALA j 89 -1 N TYR j 86 O THR j 102 SHEET 4 AB5 6 HIS j 34 ARG j 38 -1 N HIS j 34 O ALA j 89 SHEET 5 AB5 6 GLN j 45 GLY j 50 -1 O LEU j 47 N TRP j 35 SHEET 6 AB5 6 LYS j 53 ARG j 54 -1 O LYS j 53 N PHE j 49 SHEET 1 AB6 4 SER j 114 PHE j 116 0 SHEET 2 AB6 4 THR j 129 PHE j 139 -1 O LEU j 135 N PHE j 116 SHEET 3 AB6 4 TYR j 173 SER j 182 -1 O LEU j 181 N VAL j 130 SHEET 4 AB6 4 SER j 159 VAL j 163 -1 N GLN j 160 O THR j 178 SHEET 1 AB7 4 VAL j 153 LEU j 154 0 SHEET 2 AB7 4 SER j 145 VAL j 150 -1 N VAL j 150 O VAL j 153 SHEET 3 AB7 4 VAL j 191 THR j 197 -1 O THR j 197 N SER j 145 SHEET 4 AB7 4 VAL j 205 ASN j 210 -1 O PHE j 209 N TYR j 192 SSBOND 1 CYS g 23 CYS g 88 1555 1555 2.05 SSBOND 2 CYS g 134 CYS g 194 1555 1555 2.05 SSBOND 3 CYS h 22 CYS h 92 1555 1555 1.99 SSBOND 4 CYS h 140 CYS h 196 1555 1555 2.03 SSBOND 5 CYS i 22 CYS i 92 1555 1555 2.03 SSBOND 6 CYS i 140 CYS i 196 1555 1555 2.04 SSBOND 7 CYS j 23 CYS j 88 1555 1555 2.03 SSBOND 8 CYS j 134 CYS j 194 1555 1555 2.04 CISPEP 1 THR g 7 PRO g 8 0 -14.85 CISPEP 2 TYR g 140 PRO g 141 0 -3.10 CISPEP 3 PHE h 146 PRO h 147 0 -15.27 CISPEP 4 GLU h 148 PRO h 149 0 15.49 CISPEP 5 ALA i 125 PRO i 126 0 -27.66 CISPEP 6 PHE i 146 PRO i 147 0 -17.43 CISPEP 7 GLU i 148 PRO i 149 0 -2.57 CISPEP 8 LYS i 201 PRO i 202 0 22.26 CISPEP 9 THR j 7 PRO j 8 0 -10.13 CISPEP 10 PHE j 94 PRO j 95 0 7.99 CISPEP 11 TYR j 140 PRO j 141 0 -15.62 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000